TipRanks
Advertisement
Advertisement
Propanc Biopharma starts finalization of clinical trial protocol for PRP study
PremiumThe FlyPropanc Biopharma starts finalization of clinical trial protocol for PRP study
1M ago
Propanc highlights PRP as potential therapy against RAS-driven cancers
Premium
The Fly
Propanc highlights PRP as potential therapy against RAS-driven cancers
2M ago
Propanc reports new preclinical data for PRP in pancreatic ductal adenocarcinoma
Premium
The Fly
Propanc reports new preclinical data for PRP in pancreatic ductal adenocarcinoma
2M ago
Propanc CEO visits European manufacturer ahead of drug production plan
PremiumThe FlyPropanc CEO visits European manufacturer ahead of drug production plan
4M ago
ShareStructure.io Announces Investor Education Platform on Public Company Financing Activity.
Premium
TipRanks Newswire
ShareStructure.io Announces Investor Education Platform on Public Company Financing Activity.
4M ago
Propanc Biopharma announces $5M share repurchase program
Premium
The Fly
Propanc Biopharma announces $5M share repurchase program
4M ago
Propanc Biopharma files to sell 15M shares of common stock for holders
PremiumThe FlyPropanc Biopharma files to sell 15M shares of common stock for holders
6M ago
Propanc Biopharma signs multi-year collaboration with Spanish universities
Premium
The Fly
Propanc Biopharma signs multi-year collaboration with Spanish universities
6M ago
Propanc Biopharma announces highlights of PRP
Premium
The Fly
Propanc Biopharma announces highlights of PRP
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―